The revival of psychedelic research today owes much to the respectability of its new advocates.
—Michael Pollan for The New Yorker, February 2015
Conference: Clinical Research Track
Clinical Research Track
Frederick Barrett, Ph.D.
Exploring the Interaction of Psilocybin and Meditation
Michael P. Bogenschutz, M.D.
Psychedelic-Assisted Treatment of Alcohol Use Disorder: A Clinical Perspective
CE • CME
Mary Cosimano, M.S.W
Love and Connection in Psilocybin-Facilitated Research Studies
Alicia Danforth, Ph.D., and Charles S. Grob, M.D.
MDMA-Assisted Therapy for Social Anxiety in Autistic Adults: Lessons from Phase 2 Clinical Research
CE • CME
Rick Doblin, Ph.D.
The Future of Psychedelic Therapy
From Taboo to Treatment: The Evolution of Psychedelic Medicine
Albert Garcia-Romeu, Ph.D.
Optimizing Psilocybin Dosing for Clinical Precision: The Case for Weight-Adjusted Dosing
Stan Grof, M.D.
The Implications of Consciousness Research for Psychiatry, Psychology, and Psychotherapy
Matthew W. Johnson, Ph.D.
Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond
Kim Kuypers, Ph.D.
Neurobiology Underlying the Prosocial Effects of MDMA
Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N.
MDMA-Assisted Psychotherapy for PTSD: Lessons from Phase 2 Clinical Trials and Beyond
David Nichols, Ph.D.
Marcela Ot'alora, M.A., L.P.C. and Bruce Poulter, R.N., M.P.H.
MDMA as Profound Change Agent: Insights from MDMA-assisted Psychotherapy for PTSD Research
David Nutt, D.M., F.R.C.P., F.R.C.Psych, F.Med.Sci.
Psychedelic Research: From Brain Imaging to Policy Reform
The Dependent Co-Arising of Psychedelics and Meditation
Stephen Ross, M.D., and Gabby Agin-Liebes, Ph.D. Candidate
Psilocybin for Cancer-Related Anxiety and Depression: NYU Phase 2 Randomized Controlled Trial and Proposed Mechanisms
Franz X. Vollenweider, M.D., F.M.H. Psych.
Psychedelic 5HT2A Receptor Agonists Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders
Phil Wolfson M.D. and Julane Andries L.M.F.T.
MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness
CE • CME